🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John J.P. Kastelein

Korea Pharma (South Korea)

ORCID: 0000-0003-2018-4532

Also affiliated with QRx Pharma (United States), University of Amsterdam

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
10.7Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A road map for efficient and reliable human genome epidemiology

Nature Genetics(2006)10.1038/ng0106-3
Top 1%
10.4DataRank
Top 1%244 citations

John P. A. Ioannidis, Marta Gwinn, Julian Little, Julian P. T. Higgins, Jonine L. Bernstein +38 more

Papers

Driven by 15 papers — median percentile 71. Top paper: “A road map for efficient and reliable human genome epidemiology”.

A road map for efficient and reliable human genome epidemiology

Nature Genetics(2006)10.1038/ng0106-3
Top 1%
10.4DataRank
Top 1%244 citations

John P. A. Ioannidis, Marta Gwinn, Julian Little, Julian P. T. Higgins, Jonine L. Bernstein +38 more

The Emergence of Networks in Human Genome Epidemiology

Epidemiology(2007)10.1097/01.ede.0000249540.17855.b7
N/A
4.3DataRank · unranked
92 citations

Muin J. Khoury, Thomas R. O??Brien, Julian Little, Julian P. T. Higgins, Jonine L. Bernstein +35 more

A Network of Investigator Networks in Human Genome Epidemiology

American Journal of Epidemiology(2005)10.1093/aje/kwi201
N/A
4.2DataRank · unranked
118 citations

John Danesh, Siobhan Dolan, Patricia Hartge, Christopher A. Haiman, Peter Inskip +23 more

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

New England Journal of Medicine(2008)10.1056/nejmoa0807646
N/A
1.3DataRank · unranked
6588 citations

Eleanor Danielson, Francisco A.H. Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein +13 more

Defining the role of common variation in the genomic and biological architecture of adult human height

Nature Genetics(2014)10.1038/ng.3097
N/A
1.1DataRank · unranked
2093 citations

Emilio Rodríguez-Ruiz, The PAGE Consortium, Diana O. Perkins, Tonu Esko, Jian Yang +479 more

Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristics

American Heart Journal(2025)10.1016/j.ahj.2025.07.012
N/A
0.522DataRank · unranked
9 citations

Christie M. Ballantyne, Ron Blankstein, Matthew J Budoff, Marc Ditmarsch, C. Michael Gibson +8 more

Refocusing On Use of Cholesteryl Ester Transfer Protein Inhibitors

The American Journal of Cardiology(2007)10.1016/j.amjcard.2007.08.013
N/A
0.457DataRank · unranked
20 citations

John J.P. Kastelein

Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity

Current Opinion in Lipidology(2024)10.1097/mol.0000000000000955
N/A
0.396DataRank · unranked
13 citations

Andrew Hsieh, John J.P. Kastelein, Michael H. Davidson

The emergence of networks in human genome epidemiology: challenges and opportunities

Human Genome Epidemiology, 2nd Edition(2009)10.1093/acprof:oso/9780195398441.003.0007
Top 57%
0.276DataRank
Top 57%5 citations

Muin J. Khoury, Marta Gwinn, Julian Little, Julian P. T. Higgins, Jonine L. Bernstein +31 more

Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial

European Heart Journal(2024)10.1093/eurheartj/ehae614
N/A
0DataRank · unranked
26 citations

Danielle Duffy, M. Cecilia Bahit, Gerald Chi, Harvey D. White, Serge Korjian +71 more

Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.03.396
N/A
0DataRank · unranked
30 citations

Serge Korjian, M. Cecilia Bahit, Gerald Chi, Danielle Duffy, John H. Alexander +34 more

CETP and SGLT2 inhibitor combination therapy improves glycemic control

medRxiv(2023)10.1101/2023.06.13.23291357
N/A
0DataRank · unranked
0 citations

Patrick Sun, Marc Ditmarsch, John J.P. Kastelein, Michael H. Davidson, Bohdan B. Khomtchouk

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

UNC Libraries(2020)10.17615/pc2a-ev84
N/A
0DataRank · unranked
0 citations

Jeanette Erdmann, Paul L. Auer, Robert Roberts, John Danesh, Deborah Farlow +27 more

CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis

Frontiers in Endocrinology(2024)10.3389/fendo.2024.1359780
N/A
0DataRank · unranked
1 citations

Patrick Sun, Zane A. Maggio, Marc Ditmarsch, John J.P. Kastelein, Michael H. Davidson +1 more

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00040-8
N/A
0DataRank · unranked
143 citations

David Preiss, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies +95 more